Trial Profile
Diagnostic accuracy of 123I-FP-CIT dopaminergic imaging in people with neurodegenerative dementia for the clinical diagnosis of dementia with Lewy bodies
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2017
Price :
$35
*
At a glance
- Drugs Ioflupane 123I (Primary)
- Indications Dementia
- Focus Diagnostic use
- 03 Apr 2017 New trial record